Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Morris E. Feldman(Weizmann Institute of Science), Kevan M. Shokat(Howard Hughes Medical Institute), Zachary A. Knight(Howard Hughes Medical Institute), Aino Uotila(University of Geneva), Beth Apsel(Howard Hughes Medical Institute), Davide Ruggero(University of California, San Francisco), Robbie Loewith(University of Geneva)
Cited by 1,078
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k